OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2023
(3)
2025
(2)
2024
(2)
2026
(1)
2021
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Insulin-cobalt core-shell nanoparticles for receptor-targeted bioimaging and diabetic wound healing.
Not available
S-EPMC10323873
|
biostudies-literature
Cite
Protection of lead-induced cytotoxicity using paramagnetic nickel-insulin quantum clusters.
Not available
S-EPMC9036906
|
biostudies-literature
Cite
Curcumin-stabilized silver nanoparticles target the Helicobacter pylori-tumor interface in gastric cancer.
Not available
S-EPMC13473628
|
biostudies-literature
Cite
Perturbation of hyperthermia resistance in gastric cancer by hyperstimulation of autophagy using artemisinin-protected iron-oxide nanoparticles.
Not available
S-EPMC11520311
|
biostudies-literature
Cite
Chitosan-insulin nano-formulations as critical modulators of inflammatory cytokines and Nrf-2 pathway to accelerate burn wound healing.
Not available
S-EPMC10716098
|
biostudies-literature
Cite
Lactoferrin based copper nanoparticles: a promising anti-cancer strategy against malignant melanoma.
Not available
S-EPMC12485081
|
biostudies-literature
Cite
Continuous once-through electrooxidation treatment using mixed metal oxide anode for bacterial disinfection.
Not available
S-EPMC12491475
|
biostudies-literature
Cite
Integrated insulin-iron nanoparticles: a multi-modal approach for receptor-specific bioimaging, reactive oxygen species scavenging, and wound healing.
Not available
S-EPMC11139842
|
biostudies-literature
Cite
Therapeutic potential of lactoferrin-coated iron oxide nanospheres for targeted hyperthermia in gastric cancer.
Not available
S-EPMC10587155
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets